China-focused GP Hony Capital is seeing more buyout opportunities involving healthcare and restaurant chains and it has created two sector-focused operational teams to consolidate these...
Greater China | 31 Oct 2014 |
Warburg Pincus has paid INR5.5 billion ($89.6 million) for a minority stake in Indian drug maker Laurus Labs, triggering a partial exit for Fidelity Growth Partners India.
South Asia | 30 Oct 2014 |
Jaguar Animal Health, a veterinary drugs developer backed by China-focused healthcare investor BVCF, is looking to raise as much as $54 million through a NASDAQ IPO.
Exits | 29 Oct 2014 |
Luye Pharma Group, a PE-backed Chinese drug maker, has taken full ownership of its industry peer Beijing Jialin Pharmaceutical, acquiring a 42.02% interest from existing PE shareholders.
Greater China | 27 Oct 2014 |
Fidelity Growth Partners Asia has invested RMB90 million ($15 million) in Zhejiang Banger Medical Management, a Chinese orthopedic hospital operator.
Greater China | 22 Oct 2014 |
Fidelity Growth Partners and existing backer Somerset Indus CapitalFund have invested INR600 million ($9.7 million) in Cygnus Medicare, an Indian operator of specialty hospitals in Delhi and Haryana.
South Asia | 20 Oct 2014 |
BBI Life Sciences Corporation, a Chinese genetic engineering specialist backed by Qiming Venture Partners, has filed for an IPO in Hong Kong. The company has yet to disclose the size and pricing of the offering.
Exits | 17 Oct 2014 |
MID Labs, a US-based medical devices manufacturer that focuses on eye surgery, has received $51 million in funding from a group of investors to support its expansion into China.
Healthcare | 17 Oct 2014 |
Three executives from Avenue Capital, CLSA Capital Partners and VC firm Dinova Capital have teamed up to launch a $200 million mid-cap fund that will make healthcare investments in Asia.
Fundraising | 16 Oct 2014
Tencent Holdings has led a $100 million round of funding for Guahao.com, a Chinese healthcare information portal.
Greater China | 14 Oct 2014 |
Japanese security firm Alshok Group has agreed to acquire Tokyo-based healthcare service provider HCM Corporation, paving an exit for mid-market GP J-Star.
North Asia | 13 Oct 2014 |
Hony Capital has acquired Shanghai Yangsi Hospital, the largest privately-owned hospital in Shanghai. The deal size was not disclosed but it is said to amount to hundreds of millions of renminbi.
Greater China | 10 Oct 2014 |
CVC Capital Partners will raise HK$620 million ($80 million) through a block trade of shares in Jintian Pharmaceutical Group, a Chinese pharmaceutical retailer and distributor.
Greater China | 08 Oct 2014 |
When John Thomson, head of 3i Group’s Southeast Asia business, met Singaporean entrepreneur Jay Pok in the mid-2000s, he was on the lookout for a medical technology investment. But Pok’s company, medical cable maker LHi Technology, though impressive,...
Exits | 08 Oct 2014 |
A consortium of investors including Archer Capital is subject to a civil action launched by New Zealand’s Financial Markets Authority (FMA) over an unsuccessful bid for Abano Healthcare Group.
Regulation | 06 Oct 2014 |
Updating your subscription status
In 2015, China is expected to experience a "new normal of growth". For private equity investors, China's new stage of growth represents huge opportunities: an increase of 270% in online consumption, the reform of over a hundred sovereign-owned enterprises, trillion-dollar investments into overseas infrastructure projects, the rising entrance of young entrepreneurs, and many more.
To be held on 28 and 29 May, the 14th annual AVCJ China Forum 2015 in Beijing will feature these exciting topics and bring together top-notch speakers from across the world.Join the premium industrial gathering of over 300 private equity professionals, regulators and senior executives for two days of mind-provoking discussions, networking and more.
28-29 May 2015, China World Summit Wing,Beijing
There is a feeling that now is a shrewd time to invest in Japan and take advantage of the favourable conditions for private equity. Valuations are low compared with the rest of Asia and strategic buyers and the IPO market are providing an attractive route for exits. There are also signs that corporate Japan is slowly coming around to engaging PE as a potential buyer for non-core assets and recent developments at the GPIF suggest that PE will be under strong consideration for allocations from pension funds in the near future as well as regional banks committing to the asset class right now.
The macro concerns that have been present for many years still remain in terms of low growth and currency depreciation but these are encouraging times for fund managers looking to both raise capital from Japanese LPs and make investments.
245-26 June 2015, Conrad Hotel, Tokyo